Eyepoint Pharmaceuticals, Inc. 8-K Filing
Ticker: EYPT · Form: 8-K · Filed: May 28, 2024 · CIK: 1314102
| Field | Detail |
|---|---|
| Company | Eyepoint Pharmaceuticals, Inc. (EYPT) |
| Form Type | 8-K |
| Filed Date | May 28, 2024 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Eyepoint Pharmaceuticals, Inc. (ticker: EYPT) to the SEC on May 28, 2024.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ch registered Common Stock, par value $0.001 EYPT The Nasdaq Global Market Ind).
How long is this filing?
Eyepoint Pharmaceuticals, Inc.'s 8-K filing is 1 pages with approximately 418 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 418 words · 2 min read · ~1 pages · Grade level 10.5 · Accepted 2024-05-28 07:05:42
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 EYPT The Nasdaq Global Market Ind
Filing Documents
- eypt-20240528.htm (8-K) — 38KB
- eypt-ex99_1.htm (EX-99.1) — 32KB
- eypt-ex99_1s1.jpg (GRAPHIC) — 196KB
- eypt-ex99_1s2.jpg (GRAPHIC) — 815KB
- eypt-ex99_1s3.jpg (GRAPHIC) — 524KB
- eypt-ex99_1s4.jpg (GRAPHIC) — 402KB
- eypt-ex99_1s5.jpg (GRAPHIC) — 342KB
- eypt-ex99_1s6.jpg (GRAPHIC) — 473KB
- eypt-ex99_1s7.jpg (GRAPHIC) — 481KB
- eypt-ex99_1s8.jpg (GRAPHIC) — 219KB
- eypt-ex99_1s9.jpg (GRAPHIC) — 487KB
- eypt-ex99_1s10.jpg (GRAPHIC) — 333KB
- eypt-ex99_1s11.jpg (GRAPHIC) — 407KB
- eypt-ex99_1s12.jpg (GRAPHIC) — 411KB
- eypt-ex99_1s13.jpg (GRAPHIC) — 375KB
- eypt-ex99_1s14.jpg (GRAPHIC) — 319KB
- eypt-ex99_1s15.jpg (GRAPHIC) — 397KB
- eypt-ex99_1s16.jpg (GRAPHIC) — 325KB
- eypt-ex99_1s17.jpg (GRAPHIC) — 311KB
- eypt-ex99_1s18.jpg (GRAPHIC) — 289KB
- eypt-ex99_1s19.jpg (GRAPHIC) — 345KB
- eypt-ex99_1s20.jpg (GRAPHIC) — 338KB
- eypt-ex99_1s21.jpg (GRAPHIC) — 581KB
- eypt-ex99_1s22.jpg (GRAPHIC) — 508KB
- eypt-ex99_1s23.jpg (GRAPHIC) — 353KB
- eypt-ex99_1s24.jpg (GRAPHIC) — 230KB
- eypt-ex99_1s25.jpg (GRAPHIC) — 384KB
- eypt-ex99_1s26.jpg (GRAPHIC) — 380KB
- eypt-ex99_1s27.jpg (GRAPHIC) — 202KB
- eypt-ex99_1s28.jpg (GRAPHIC) — 440KB
- eypt-ex99_1s29.jpg (GRAPHIC) — 207KB
- eypt-ex99_1s30.jpg (GRAPHIC) — 486KB
- eypt-ex99_1s31.jpg (GRAPHIC) — 331KB
- eypt-ex99_1s32.jpg (GRAPHIC) — 210KB
- eypt-ex99_1s33.jpg (GRAPHIC) — 502KB
- eypt-ex99_1s34.jpg (GRAPHIC) — 274KB
- eypt-ex99_1s35.jpg (GRAPHIC) — 382KB
- eypt-ex99_1s36.jpg (GRAPHIC) — 192KB
- 0000950170-24-064879.txt ( ) — 18711KB
- eypt-20240528.xsd (EX-101.SCH) — 23KB
- eypt-20240528_htm.xml (XML) — 4KB
01 Other Events
Item 8.01 Other Events. On May 28, 2024, EyePoint Pharmaceuticals, Inc. posted an updated investor presentation on its website at www.eyepointpharma.com. A copy of the presentation is filed herewith as Exhibit 99.1 and is incorporated by reference herein.
01 Financial Statements and Exhibits
Item 9.01 Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Investor Presentation of EyePoint Pharmaceuticals, Inc. dated May 28, 2024 104 Cover Page Interactive Data File (embedded within the inline XBRL document)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EYEPOINT PHARMACEUTICALS, INC. Date: May 28, 2024 By: /s/ George O. Elston George O. Elston Executive Vice President and Chief Financial Officer